Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

NCT05750706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-05-06

No results posted yet for this study

Summary

The study aims to evaluate incidence of invasive antifungal infections among patients with acute lymphoblastic leukemia Ph negative during the first weeks of treatment

Conditions

  • Acute Lymphoblastic Leukemia, Adult
  • Invasive Fungal Infections

Interventions

OTHER

observation of invasive fungal infections

observation of invasive fungal infections during chemotherapy

Sponsors & Collaborators

  • Asst Degli Spedali Civili Di Brescia

    collaborator OTHER
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    collaborator OTHER
  • Campus Bio-Medico University

    collaborator OTHER
  • Azienda Sanitaria Universitaria Friuli Centrale

    collaborator OTHER
  • San Gallicano Dermatological Institute IRCCS

    collaborator OTHER
  • University of Rome Tor Vergata

    collaborator OTHER
  • University of Modena and Reggio Emilia

    collaborator OTHER
  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    collaborator OTHER
  • Vito Fazzi Hospital

    collaborator UNKNOWN
  • Azienda Ospedaliera di Padova

    collaborator OTHER
  • San Raffaele University Hospital, Italy

    collaborator OTHER
  • Azienda Ospedaliera Universitaria Integrata Verona

    collaborator OTHER
  • Azienda Ospedaliero-Universitaria di Parma

    collaborator OTHER
  • Azienda Ospedaliera "Sant'Andrea"

    collaborator OTHER
  • S.Eugenio Hospital

    collaborator OTHER
  • San Giovanni Addolorata Hospital

    collaborator OTHER
  • Casa Sollievo della Sofferenza-IRCCS, San Giovanni Rotondo

    collaborator UNKNOWN
  • ASST Sette Laghi

    collaborator OTHER
  • Ospedale San Bortolo di Vicenza

    collaborator OTHER
  • Fondazione IRCCS Policlinico San Matteo di Pavia

    collaborator OTHER
  • A.O.U. Città della Salute e della Scienza

    collaborator OTHER
  • Istituto Oncologico Veneto IRCCS

    collaborator OTHER
  • Azienda Ospedaliera San Gerardo di Monza

    collaborator OTHER
  • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

    collaborator OTHER
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Marianna Criscuolo · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05750706 on ClinicalTrials.gov